IMUP - Centre for Immunopharmacology in Transplantation
IMUP is a research centre joined by four groups located at the Rikshospitalet University Hospital and the University of Oslo.
The overall aim is to improve the immunosuppressive treatment in organ transplant recipients. Research methods in these groups span from experiments in cultured cells to clinical investigations in transplanted patients..
Jan 31, 2012
At the annual meeting of The Norwegian Society of Pharmacology and Toxicology at Beito, January 26 to 28, members of IMUP contributed a list of presentations and were even awarded a prize.
Nov 14, 2011
A group led by Dr. Teun Van Gelder on behalf of ESOT has provided reccomendation on generic substitution of immunsosuppressives in transplanted patients
Oct 10, 2011
Seven scientists from our group attended the IATDMCT meeting in Stuttgart in October. Several presentations from these attendees made this into the broadest presentation ever of our research activities at such a high level international meeting.
Sep 4, 2011
Dr. Midtvedt and co-workers have investigated the switch from Prograf to the new once daily formulation of tacrolimus (Advagraf). No positive effects on glucose metabolism were found following switch but the overall systemic exposure of tacrolimus was reduced. Intensified TDM is therefore reccomended when switching.
Jul 17, 2011
Prof. Hartmanns groups has reviewed all cases of ganciclovir resistance in renal transplant recipients in Norway. The term "resistance" is a graded situation in this population and many of the resistant cases were successfully treated by increaseing the ganciclovir dose and/or reducing the over all immunosuppression of the patients.